Skip to main content
. 2013 Jun 1;7(6):1120–1124. doi: 10.7860/JCDR/2013/4742.3027

[Table/Fig-4]:

Time to Disease Progression (TTP)

Intaxel Taxol
Number Randomized 25 24
No. of subjects with Disease Progression 11 9
No. of subjects without Disease Progression (censored) 14 (56%) 15(63%)
Median TTP (days) 157 222
95% Lower Confidence Interval TTP (days) 122 134
Hazard Ratio (95% Confidence Limits) 1.525 (0.612, 3.797)
Log-Rank p-values 0.3607